Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly vs weekly oral risedronate with vitamin D in Korean postmenopausal osteoporotic women
KCT0001538Phase 4Active, not recruiting
- Sponsor
- Hanlim Pharm
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in osteoporosis, sponsored by Hanlim Pharm. Started Dec 2012; status: active, not recruiting.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on KCT0001538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001538.